Logo image of CTMX

CYTOMX THERAPEUTICS INC (CTMX) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:CTMX - US23284F1057 - Common Stock

4.35 USD
+0.09 (+2.11%)
Last: 1/9/2026, 8:00:01 PM
4.29 USD
-0.06 (-1.38%)
After Hours: 1/9/2026, 8:00:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
CTMX revenue by date.CTMX revenue by date.
53.2M
42.63%
101.214M
90.25%
138.103M
36.45%
85.407M
-38.16%
42.094M
-50.71%
47.532M
12.92%
49.886M
4.95%
126.19M
152.96%
191.37M
51.65%
276.89M
44.69%
378.14M
36.57%
EBITDA
YoY % growth
CTMX ebitda by date.CTMX ebitda by date.
-91.2M
19.51%
-4.309M
95.28%
26.763M
721.10%
-7.14M
-126.68%
-72.42M
-914.29%
-114.24M
-57.75%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
CTMX ebit by date.CTMX ebit by date.
-93.6M
19.31%
-6.484M
93.07%
24.995M
485.49%
-9.114M
-136.46%
-76.1M
-734.97%
-88.119M
-15.79%
-74.107M
15.90%
-23.834M
67.84%
27.63M
215.93%
92.112M
233.38%
39.78M
-56.81%
Operating Margin
CTMX operating margin by date.CTMX operating margin by date.
-175.94%-6.41%18.10%-10.67%-180.79%-185.39%-148.55%-18.89%14.44%33.27%10.52%
EPS
YoY % growth
CTMX eps by date.CTMX eps by date.
-1.52
-16.03%
-0.02
98.68%
0.39
2,050.00%
-0.01
-103.40%
-0.39
-2,866.38%
-0.43
-9.95%
-0.30
31.60%
-0.32
-6.90%
-0.21
32.26%
0.18
185.71%
0.54
194.44%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.07
-128.99%
-0.10
-137.59%
-0.06
-5,408.00%
-0.12
-35.15%
-0.13
-91.57%
Revenue
Q2Q % growth
8.3M
-78.21%
6.798M
-86.65%
15.086M
-19.14%
4.886M
-18.06%
4.886M
-41.13%
EBITDA
Q2Q % growth
1.02M
-94.75%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-12.14M
-168.67%
-17.002M
-175.16%
-19.807M
-1,440.23%
-20.827M
-32.09%
-22.612M
-86.26%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.09
-228.57%
-0.05-0.04-74.27%
Q2 2025
Q2Q % growth
0.00
98.75%
-0.080.0898.72%
Q1 2025
Q2Q % growth
0.27
58.82%
0.130.14113.47%
Q4 2024
Q2Q % growth
0.23
2,200.00%
-0.200.43215.22%
Q3 2024
Q2Q % growth
0.07
75.00%
-0.180.25139.87%
Q2 2024
Q2Q % growth
-0.08
-300.00%
-0.150.0745.28%
Q1 2024
Q2Q % growth
0.17
440.00%
-0.080.25301.22%
Q4 2023
Q2Q % growth
0.01
102.33%
-0.030.04134.32%
Q3 2023
Q2Q % growth
0.04
111.43%
-0.190.23120.76%
Q2 2023
Q2Q % growth
-0.02
94.59%
-0.210.1990.44%
Q1 2023
Q2Q % growth
-0.05
86.49%
-0.110.0653.65%
Q4 2022
Q2Q % growth
-0.43
-7.50%
-0.24-0.19-78.96%
Q3 2022
Q2Q % growth
-0.35 -0.31-0.04-12.30%
Q2 2022
Q2Q % growth
-0.37
-23.33%
-0.370.00-0.76%
Q1 2022
Q2Q % growth
-0.37
-42.31%
-0.370.000.16%
Q4 2021
Q2Q % growth
-0.40
-25.00%
-0.29-0.11-38.95%
Q3 2021
Q2Q % growth
-0.35
-9.37%
-0.32-0.03-9.80%
Q2 2021
Q2Q % growth
-0.30
11.76%
-0.330.037.88%
Q1 2021
Q2Q % growth
-0.26
-200.00%
-0.350.0926.29%
Q4 2020
Q2Q % growth
-0.32 -0.510.1937.70%
Q3 2020
Q2Q % growth
-0.32 -0.490.1734.13%
Q2 2020
Q2Q % growth
-0.34 0.16-0.50-313.13%
Q1 2020
Q2Q % growth
0.26 -0.470.73155.29%
CTMX Yearly EPS VS EstimatesCTMX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 -0.5 -1 -1.5 -2
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
5.963M
-82.16%
11.858M-5.895M-49.71%
Q2 2025
Q2Q % growth
18.658M
-25.71%
15.076M3.582M23.76%
Q1 2025
Q2Q % growth
50.917M
22.80%
31.455M19.462M61.87%
Q4 2024
Q2Q % growth
38.093M
43.17%
19.805M18.288M92.34%
Q3 2024
Q2Q % growth
33.432M
26.71%
17.865M15.567M87.14%
Q2 2024
Q2Q % growth
25.115M
1.58%
20.395M4.72M23.14%
Q1 2024
Q2Q % growth
41.463M
76.45%
21.863M19.6M89.65%
Q4 2023
Q2Q % growth
26.607M
2,700.74%
21.464M5.143M23.96%
Q3 2023
Q2Q % growth
26.384M
136.63%
14.424M11.96M82.92%
Q2 2023
Q2Q % growth
24.724M
92.40%
14.159M10.565M74.62%
Q1 2023
Q2Q % growth
23.499M
159.94%
19.98M3.519M17.61%
Q4 2022
Q2Q % growth
950K
107.58%
18.204M-17.254M-94.78%
Q3 2022
Q2Q % growth
11.15M
-36.61%
18.516M-7.366M-39.78%
Q2 2022
Q2Q % growth
12.85M
-21.12%
18.259M-5.409M-29.62%
Q1 2022
Q2Q % growth
9.04M
-43.39%
21.077M-12.037M-57.11%
Q4 2021
Q2Q % growth
-12.53M
-176.54%
25.003M-37.533M-150.11%
Q3 2021
Q2Q % growth
17.59M
-1.12%
18.446M-856K-4.64%
Q2 2021
Q2Q % growth
16.29M
-1.93%
17.202M-912K-5.30%
Q1 2021
Q2Q % growth
15.97M
-67.80%
15.735M235K1.49%
Q4 2020
Q2Q % growth
16.37M 15.718M652K4.15%
Q3 2020
Q2Q % growth
17.79M 16.67M1.12M6.72%
Q2 2020
Q2Q % growth
16.61M 49.174M-32.564M-66.22%
Q1 2020
Q2Q % growth
49.59M 20.276M29.314M144.57%
CTMX Yearly Revenue VS EstimatesCTMX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -21.64% 0% -139.79%
Revenue0% -32.96% 0% -10.16%